US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.36

+0.07930.43%

Post-market: 18.30-0.0588-0.32%19:30 EDT

Volume:30.01K

Turnover:549.75K

Market Cap:108.32M

PE:- -

High:18.43

Open:18.31

Low:18.20

Close:18.28

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:1.09

T/O Rate:0.51%

Dividend:0.71

Dividend Rate:3.89%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

CSPC Pharmaceutical Group Stock Rises 0.9% in Hong Kong, Outperforms Competitors

WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics

Akeso Wins China NMPA Phase I Clearance for Egfr/trop2 Bispecific ADC Ak158d1

RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/KURE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.3593,"timestamp":1789761600000,"preClose":18.28,"halted":0,"volume":30007,"hourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"delay":0,"changeRate":0.004338074398249449,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Market Closed","change":0.0793,"latestTime":"09-18 16:00:00 EDT","open":18.31,"high":18.4299,"low":18.2,"amount":549746.6642979999,"amplitude":0.012577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.28,"sharesOutstanding":4750002,"nav":18.2,"aum":106490719.49,"dividendRate":0.038934,"bidAskSpread":0.011872,"postHourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"volumeRatio":1.0912112465055275,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0912112465055275,"shares":5900168,"dividePrice":0.7148,"high":18.4299,"amplitude":0.012577,"preClose":18.28,"low":18.2,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":18.3593,"eps":0,"divideRate":0.038934,"volume":30007,"delay":0,"ttmEps":0,"open":18.31,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":17.74,"twentyDayClose":19.34,"sixtyDayClose":15.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668491989","title":"CSPC Pharmaceutical Group Stock Rises 0.9% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2668491989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668491989?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:33","pubTimestamp":1789720380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. inched 0.9% higher to 8.93 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 24750.78.This was the stock's third consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 19% short of its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.5%, SSY Group Ltd. fell 2.0%, and United Laboratories International Holdings Ltd. rose 1.7%.Trading volume totaled 79.1 million shares, compared to the 50-day average of 99.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1226287875.USD","IE00BZ08YT58.USD","LU1226288253.USD","LU1226288170.HKD","LU1008478684.HKD","BK1515","LU1960683339.HKD","SG9999004220.SGD","HK0000165453.HKD","LU1226287529.USD","LU1226287792.SGD","LU0140636845.USD","LU0314109678.HKD","BK1191","IE0008369823.USD","LU0315179316.USD","LU1152091754.HKD","BK1521","LU1328277881.USD","LU1152091168.USD","LU1813983027.USD","LU0072913022.USD","LU0326950275.SGD","IE00B031HY20.USD","LU0880133367.SGD","IE00B5MMRT66.SGD","LU1951186391.HKD","KURE","IE00B543WZ88.USD","LU1993786604.SGD","LU0501845795.SGD","IE0008368742.USD","01093","LU0067412154.USD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668957642","title":"WuXi XDC Out-Licenses WuXiTecan-2 ADC Payload-Linker Platform to Ona Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2668957642","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668957642?lang=en_us&edition=fundamental","pubTime":"2026-09-17 16:10","pubTimestamp":1789632627,"startTime":"0","endTime":"0","summary":"WuXi XDC out-licenses WuXiTecan-2 ADC payload-linker platform to Ona TherapeuticsWuXi XDC out-licensed its WuXiTecan-2 payload-linker platform to Ona Therapeutics for a single-target antibody-drug con","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL4Jm48D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","LU1794554557.SGD","LU0359201612.USD","LU0819121731.USD","LU0039217434.USD","02269","LU1720050803.USD","LU0463099449.HKD","LU0516423091.SGD","LU0348827113.USD","LU0307460666.USD","LU0979878070.USD","LU0140636845.USD","LU0823426480.USD","LU0456846285.SGD","LU0417516902.SGD","LU0708995583.HKD","LU0634319403.HKD","02268","LU0348825331.USD","LU0823426308.USD","LU1688375341.USD","BK1589","BK1576","LU2039709279.SGD","LU1188198961.HKD","LU3063872942.SGD","LU0516422366.SGD","LU0417516738.SGD","LU0320764599.SGD","LU0327786744.USD","LU0052750758.USD","LU2488822045.USD","SG9999002562.SGD","KURE","LU0540923850.HKD","LU0572944931.SGD","LU0359202008.SGD","LU0516422952.EUR","LU0588546209.SGD","BK1141","LU1880383366.USD","SG9999014674.SGD","LU0181495838.USD","LU0516423174.USD","LU0856984785.SGD","LU0348735423.USD","LU0456827905.SGD","SG9999002463.SGD","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668951651","title":"Akeso Wins China NMPA Phase I Clearance for Egfr/trop2 Bispecific ADC Ak158d1","url":"https://stock-news.laohu8.com/highlight/detail?id=2668951651","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668951651?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:35","pubTimestamp":1789626955,"startTime":"0","endTime":"0","summary":"Akeso wins China NMPA Phase I clearance for EGFR/TROP2 bispecific ADC AK158D1China’s NMPA cleared a Phase I trial for Akeso’s EGFR/TROP2 bispecific ADC candidate AK158D1 in advanced solid tumors.The d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL48Q7TK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU2476274308.USD","LU0348825331.USD","LU1720050803.USD","LU0348783233.USD","BK1574","LU0417516738.SGD","LU0417516902.SGD","BK1161","LU2476274720.SGD","LU0348735423.USD","LU0348827113.USD","LU0417516571.SGD","LU1961090484.USD","LU2778985437.USD","LU0348767384.USD","LU2399975544.HKD","LU0348766576.USD","IE00B5MMRT66.SGD","KURE","09926","LU0540923850.HKD","LU0561508036.HKD","IE00BPRC5H50.USD","LU0634319403.HKD","LU0348784397.USD","LU2488822045.USD","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113110252","title":"RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1113110252","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113110252?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:20","pubTimestamp":1789626032,"startTime":"0","endTime":"0","summary":"The valuation of innovative drug companies is fundamentally anchored to their pipeline value, and for RemeGen, the PD-1/VEGF bispecific antibody RC148—its core asset in the tumor immunotherapy...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","09995","LU0348827113.USD","LU2476274308.USD","LU1969619763.USD","BK1574","BK1161","LU2148510915.USD","LU2476274720.SGD","LU2488822045.USD","LU2399975544.HKD","BK1583","LU1720050803.USD","IE00BPRC5H50.USD","LU1064131003.USD","LU0348783233.USD","BK0239","LU1961090484.USD","LU0348825331.USD","LU0348784397.USD","LU2328871848.SGD","LU0348735423.USD","LU0417516902.SGD","LU0348766576.USD","LU0348767384.USD","09926","IE00B5MMRT66.SGD","LU2778985437.USD","KURE","LU0417516738.SGD","LU0417516571.SGD","LU0634319403.HKD","LU0561508036.HKD","LU0540923850.HKD","IE00B543WZ88.USD","688331","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KURE\",params:#limit:6,delay:false,,,undefined,":[]}}